Cargando…
Development of lifitegrast: a novel T-cell inhibitor for the treatment of dry eye disease
Dry eye disease (DED) is a multifactorial disorder of the ocular surface characterized by symptoms of discomfort, decreased tear quality, and chronic inflammation that affects an estimated 20 million patients in the US alone. DED is associated with localized inflammation of the ocular surface and pe...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove Medical Press
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4910612/ https://www.ncbi.nlm.nih.gov/pubmed/27354762 http://dx.doi.org/10.2147/OPTH.S110557 |